Good work Jerry,What are the implications for Relenza when the...

Good work Jerry,

What are the implications for Relenza when the US which is the heartland for Tamiflu is moving to 50:50?

All BTA shareholders should email the
“NATIONAL BIODEFENSE SCIENCE BOARD + + + + +
PUBLIC MEETING + + + + +
FRIDAY, SEPTEMBER 25, 2009” document discovered by Jerry to your Health Minister and ask why Australia should not be stocking 50:50?

Readers in EU/Germany should also inform their respective Health Authorities.

Here’s the link Jerry had previously provided:
http://www.hhs.gov/aspr/conferences/nbsb/nbsb-mtgtrnscrpt-090925.pdf

And we also have the Bloomberg news clearly stating that health authorities are recommending using Relenza first before Tamiflu. Here’s the link again:
http://www.youtube.com/watch?v=xz2_64SlAKY&NR=1

These are all rock-solid credible sources.
The chorus should email it to the idiot CEO Peter Cook.
BTA shareholders had missed out on the bonus opportunities from the Avian Flu, the $100m GSK settlement offer. Are we going to miss out again on the Swine flu due to a restricted GSK production? GSK could increased normal Relenza from the 30 million to 60 million in 8 weeks to June. I cannot understand why they planned the increase from 60 million to 90 million (normal relenza) by 1 Jan 2010?

All these sources including earlier news from Taiwan, Japan etceteras clearly indicated the sales of Relenza is restricted only by supply! What is it that BTA management can not understand? How could they be happy with GSK and singing praises to GSK?